Literature DB >> 16400181

Cellular and molecular biology of Candida albicans estrogen response.

Georgina Cheng1, Kathleen M Yeater, Lois L Hoyer.   

Abstract

Candida albicans is the most common etiological agent of vaginal candidiasis. Elevated host estrogen levels and the incidence of vaginal candidiasis are positively associated. Elevated estrogen levels may affect host and/or fungal cells. This study investigates the effect of 17-beta-estradiol, 17-alpha-estradiol, ethynyl estradiol, and estriol on several C. albicans strains at concentrations ranging from 10(-5) to 10(-10) M. The addition of 17-beta-estradiol or ethynyl estradiol to C. albicans cells caused an increase in the number of cells forming germ tubes and an increase in germ tube length in a dose- and strain-dependent manner. The addition of 17-alpha-estradiol or estriol did not have a significant effect on germ tube formation by the cultured cells. Exposure to exogenous estrogens did not significantly change the biomass of any C. albicans culture tested. The transcriptional profile of estrogen-treated C. albicans cells showed increased expression of CDR1 and CDR2 across several strain-estrogen concentration-time point combinations, suggesting that these genes are the most responsive to estrogen exposure. Analysis of strain DSY654, which lacks the CDR1 and CDR2 coding sequences, showed a significantly decreased number of germ tube-forming cells in the presence of 17-beta-estradiol. PDR16 was the most highly up-regulated gene in strain DSY654 under these growth conditions. The cell biology and gene expression data from this study led to a model that proposes how components of the phospholipid and sterol metabolic pathways may interact to affect C. albicans germ tube formation and length.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400181      PMCID: PMC1360257          DOI: 10.1128/EC.5.1.180-191.2006

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  49 in total

Review 1.  Biological functions of phosphatidylinositol transfer proteins.

Authors:  Sheri M Routt; Vytas A Bankaitis
Journal:  Biochem Cell Biol       Date:  2004-02       Impact factor: 3.626

2.  Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

Authors:  Dominique Sanglard; Françoise Ischer; Michel Monod; Jacques Bille
Journal:  Microbiology (Reading)       Date:  1997-02       Impact factor: 2.777

3.  Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis.

Authors:  Catriona Susan Bradshaw; Anna N Morton; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Christopher K Fairley
Journal:  Obstet Gynecol       Date:  2005-07       Impact factor: 7.661

4.  Propranolol inhibits hyphal development in Candida albicans.

Authors:  Carol A Baker; Kevin Desrosiers; Joseph W Dolan
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Phospholipase D activity is required for dimorphic transition in Candida albicans.

Authors:  Nealoo McLain; Joseph W Dolan
Journal:  Microbiology (Reading)       Date:  1997-11       Impact factor: 2.777

Review 6.  Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

Authors:  J D Sobel; S Faro; R W Force; B Foxman; W J Ledger; P R Nyirjesy; B D Reed; P R Summers
Journal:  Am J Obstet Gynecol       Date:  1998-02       Impact factor: 8.661

7.  Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; S L Hillier; R S Gibbs; D A Eschenbach
Journal:  Am J Obstet Gynecol       Date:  1998-02       Impact factor: 8.661

8.  SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.

Authors:  Neerja Karnani; Naseem Akhtar Gaur; Sudhakar Jha; Neeti Puri; Shankarling Krishnamurthy; Shyamal K Goswami; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Yeast       Date:  2004-02       Impact factor: 3.239

9.  Constitutive activation of the PDR16 promoter in a Candida albicans azole-resistant clinical isolate overexpressing CDR1 and CDR2.

Authors:  Xavier De Deken; Martine Raymond
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  The impact of oral contraception on vulvovaginal candidiasis.

Authors:  A Spinillo; E Capuzzo; S Nicola; F Baltaro; A Ferrari; A Monaco
Journal:  Contraception       Date:  1995-05       Impact factor: 3.375

View more
  22 in total

Review 1.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

2.  Aneuploid chromosomes are highly unstable during DNA transformation of Candida albicans.

Authors:  Kelly Bouchonville; Anja Forche; Karen E S Tang; Anna Selmecki; Judith Berman
Journal:  Eukaryot Cell       Date:  2009-08-21

3.  Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p.

Authors:  Luiz R Basso; Charles E Gast; Yuxin Mao; Brian Wong
Journal:  Eukaryot Cell       Date:  2010-03-26

4.  Mouse strain-dependent differences in estrogen sensitivity during vaginal candidiasis.

Authors:  Paolo Mosci; Donatella Pietrella; Giovanni Ricci; Neelam Pandey; Claudia Monari; Eva Pericolini; Elena Gabrielli; Stefano Perito; Francesco Bistoni; Anna Vecchiarelli
Journal:  Mycopathologia       Date:  2012-10-07       Impact factor: 2.574

Review 5.  The ABCs of Candida albicans Multidrug Transporter Cdr1.

Authors:  Rajendra Prasad; Atanu Banerjee; Nitesh Kumar Khandelwal; Sanjiveeni Dhamgaye
Journal:  Eukaryot Cell       Date:  2015-09-25

6.  Responses of pathogenic and nonpathogenic yeast species to steroids reveal the functioning and evolution of multidrug resistance transcriptional networks.

Authors:  Dibyendu Banerjee; Gaelle Lelandais; Sudhanshu Shukla; Gauranga Mukhopadhyay; Claude Jacq; Frederic Devaux; Rajendra Prasad
Journal:  Eukaryot Cell       Date:  2007-11-09

7.  A genome-wide steroid response study of the major human fungal pathogen Candida albicans.

Authors:  Dibyendu Banerjee; Nuria Martin; Soumyadeep Nandi; Sudhanshu Shukla; Angel Dominguez; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Mycopathologia       Date:  2007-06-16       Impact factor: 2.574

Review 8.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

9.  Influence of 17β-estradiol on gene expression of Paracoccidioides during mycelia-to-yeast transition.

Authors:  Jata Shankar; Thomas D Wu; Karl V Clemons; Jomar P Monteiro; Laurence F Mirels; David A Stevens
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 10.  Efflux in fungi: la pièce de résistance.

Authors:  Jeffrey J Coleman; Eleftherios Mylonakis
Journal:  PLoS Pathog       Date:  2009-06-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.